Who owns Pacira BioSciences, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of PCRX from SEC Form 13F filings across 181 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 181 institutions disclosed 32.9M shares of Pacira BioSciences, Inc. worth $822.4M — about 83.5% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
181
13F holders
$822.4M
value, 2026 filers
83.5%
of shares outstanding (32.9M sh)
32
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of PCRX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 6.7M | $170.1M | 0.0% | 17% | -0.4% |
| 2 | Doma Perpetual Capital Management LLC | 2.8M | $70.5M | 16.4% | 7% | 0.0% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.4M | $61.0M | 0.0% | 6.1% | -3.8% |
| 4 | D. E. Shaw & Co., Inc. | 2.0M | $49.5M | 0.0% | 4.9% | -1.6% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 1.7M | $42.9M | 0.0% | 4.3% | -52.6% |
| 6 | GOLDMAN SACHS GROUP INC | 1.5M | $38.7M | 0.0% | 3.9% | -2.7% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.2M | $29.4M | 0.0% | 2.9% | +1.3% |
| 8 | MORGAN STANLEY | 1.1M | $29.0M | 0.0% | 2.9% | -17.8% |
| 9 | AMERICAN CENTURY COMPANIES INC | 1.0M | $25.8M | 0.0% | 2.6% | +21.6% |
| 10 | UBS Group AG | 920,217 | $23.3M | 0.0% | 2.3% | +63.7% |
| 11 | TWO SIGMA INVESTMENTS, LP | 724,604 | $18.4M | 0.0% | 1.8% | +37.5% |
| 12 | Sixth Street Partners Management Company, L.P.NEW | 690,786 | $17.5M | 3.0% | 1.8% | new |
| 13 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 690,786 | $17.5M | 0.0% | 1.8% | -5.6% |
| 14 | WELLINGTON MANAGEMENT GROUP LLP | 563,458 | $14.3M | 0.0% | 1.4% | +17.8% |
| 15 | NORTHERN TRUST CORP | 526,782 | $13.4M | 0.0% | 1.3% | +1.4% |
| 16 | DEUTSCHE BANK AG\ | 391,101 | $9.9M | 0.0% | 1% | -0.1% |
| 17 | Gagnon Advisors, LLC | 352,637 | $8.9M | 5.7% | 0.9% | 0.0% |
| 18 | JPMORGAN CHASE & CO | 346,697 | $8.7M | 0.0% | 0.9% | +44.2% |
| 19 | BARCLAYS PLC | 310,189 | $7.9M | 0.0% | 0.8% | +10.0% |
| 20 | Bank of New York Mellon Corp | 296,880 | $7.5M | 0.0% | 0.8% | -1.9% |
| 21 | PRINCIPAL FINANCIAL GROUP INC | 281,017 | $7.1M | 0.0% | 0.7% | -0.8% |
| 22 | Public Sector Pension Investment Board | 270,376 | $6.9M | 0.0% | 0.7% | +83.9% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 261,457 | $6.6M | 0.0% | 0.7% | -2.4% |
| 24 | Cambridge Investment Research Advisors, Inc. | 255,992 | $6,494 | 0.0% | 0.6% | +108.5% |
| 25 | Invesco Ltd. | 249,350 | $6.3M | 0.0% | 0.6% | +5.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.